+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bayer AG - logo

Bayer is a global enterprise with a 150 year history in the Life Sciences focused on developing innovative products in the fields of health care and agriculture. Bayer works to meet some of the biggest challenges facing the world today such as the need to promote sustainable agricultural practices to ensure an adequate supply of food and renewable raw materials for the expanding global population as well as working to improve quality of life in an aging society through the prevention and treatment of disease. The Bayer Group is comprised of approx. 302 consolidated companies in 75 countries throughout the world and its headquarters are in Leverkusen, Germany. Bayer became the sole owner of Monsanto Company on June 7 2018.

Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 196 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 179 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 181 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • December 2025
  • 180 Pages
  • Global
From
Pulmonary Edema Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Edema Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 285 Pages
  • Global
From
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 387 Pages
  • Global
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 293 Pages
  • Global
From
Dyslipidemia Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs Market - Global Strategic Business Report

  • Report
  • December 2025
  • 268 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • December 2025
  • 187 Pages
  • Global
From
Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • December 2025
  • 139 Pages
  • Global
From
From
Cardiotonic Agents Market - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents Market - Global Strategic Business Report

  • Report
  • December 2025
  • 568 Pages
  • Global
From
Long QT Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Long QT Syndrome Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 277 Pages
  • Global
From
From
Pericarditis Drugs - Global Strategic Business Report - Product Thumbnail Image

Pericarditis Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 289 Pages
  • Global
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 413 Pages
  • Global
From
Eczema Therapeutics Market 2024-2028 - Product Thumbnail Image

Eczema Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 172 Pages
  • Global
From
Canola Meal - Global Strategic Business Report - Product Thumbnail Image

Canola Meal - Global Strategic Business Report

  • Report
  • December 2025
  • 193 Pages
  • Global
From
Loading Indicator